✦ LIBER ✦

Clearance rates of cerivastatin metabolites in a patient with cerivastatin-induced rhabdomyolysis

✍ Scribed by H. Ozaki; C. T. Ishikawa; T. Ishii; A. Toyoda; T. Murano; Y. Miyashita; K. Shirai

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A frameshift variant of CYP2C8 was ident

✍ Chikako Ishikawa; Hiroshi Ozaki; Toshiaki Nakajima; Toshihiro Ishii; Saburo Kana 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 312 KB

Cerivastatin, a new synthetic HMG CO-A r

✍ V.V. Kukharchuk; E.Yu. Solovieva; T.A. Rozhkova; M.G. Tvorogova 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 272 KB

Effects of cerivastatin sodium, a new HM

✍ Susumu Tazuma; Gunji Yamashita; Hidenori Ochi; Hiroyuki Miura; Tsuyoshi Kajihara 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 576 KB

A long-term comparative trial of cerivas

✍ Jun Sasaki; Kikuo Arakawa; Kyosuke Yamamoto; Shozo Kobori; Masato Ageta; Suminor 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 658 KB

Clearance of myoglobin by high cutoff co

✍ Wu, Buyun; Gong, Dehua; Ji, Daxi; Xu, Bin; Liu, Zhihong 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

CAVEAT: A comparison of cerivastatin 0.4

✍ Ma, P.; Hegele, R.; Yale, J.F.; Schwartz, B. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 173 KB